PP3 - Estimating the Health State Utility of Patients with HER2– gBRCA+ Metastatic Breast Cancer Treated with Olaparib or Chemotherapy Via A Mapping Analysis of Eortc QLQ-C30 Data Collected in the Olympiad Clinical Trial
- Resource Type
- Abstract
- Source
- In
Value in Health May 2018 21 Supplement 1:S12-S12 - Subject
- Language
- ISSN
- 1098-3015